Johanna W. Baars

Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli et al. · New England Journal of Medicine · 2003 · 306 citations · Full text

Activated Cytotoxic T Cells as Prognostic Marker in Hodgkin's Disease

J J Oudejans, Natasha Jiwa, J. Alain Kummer et al. · Blood · 1997 · 136 citations

Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway

Gertjan Wolbink, J. Bollen, Johanna W. Baars et al. · Journal of Immunological Methods · 1993 · 118 citations

Complement System, Immunocytochemical Technique, Allergy +13

Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia

Johanna W. Baars, Jan Paul de Boer, John Wagstaff et al. · British Journal of Haematology · 1992 · 60 citations

Il-2 Therapy, Immunology, Pharmacotherapy +22

Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2

J. J. Heimans, John Wagstaff, W. O. Schreuder et al. · Surgical Neurology · 1991 · 23 citations

Ophthalmology, Leptomeningeal Carcinomatosis, Immunology +4